Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube

Related Information

Downloads and Links

US Medical Device Regulations and Regulatory Landscape Mike Winegar
Vice President Regulatory Affairs, Medpace Medical Device

MORE more

QT Evaluation in Early Clinical Development Thomas Todaro, MD, JD, FACC
Medpace Vice President, Medical Affairs

MORE more

Oncology studies demand a specialized team who understands and can readily execute the scientific and regulatory issues that are most relevant to the program. Our oncology teams are built to work quickly, tactically and honestly with Sponsor and sites in a partnership philosophy. Focused oncology teams allow effective trial planning and execution from protocol development to database lock. Medpace works proactively to identify potential issues of concern, and provides solutions for the most efficient and successful trial.

With experience in trials from early through late phase development (Phase I – IV), including classic multi-cytotoxic agent and targeted and/or biologic therapy trials, the oncologic experts at Medpace deliver rapid and accurate results in trials of varied scope – from small, focused trials to large global studies.

There is an urgent need to develop new oncologic therapies. But oncology clinical trials are longer and more complex than those in any other therapeutic area. The complexity of development demands the right kind of research partner. Powerful solutions demand the thought leaders at Medpace.

Oncology clinical and regulatory experience

  • Gastro-intestinal cancer
  • Gynecologic cancer
  • Genito-urinary cancer
  • Head-and-neck cancer
  • Leukemia and other hematologic malignancies
  • Lymphoma
  • Lung cancer
  • Melanoma
  • Palliative care
  • Pediatric malignancies
  • Sarcoma
  • Tumors of the CNS

>> Click here to request more information about Medpace's capabilities and therapeutic expertise in oncology.